Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts

Aethlon Medical Return on Investment 2012-2025 | AEMD

Current and historical return on investment (ROI) values for Aethlon Medical (AEMD) over the last 10 years.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Aethlon Medical ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-12-31 $-0.01B 0.00%
2025-09-30 $-0.01B 0.00%
2025-06-30 $-0.01B 0.00%
2025-03-31 $-0.01B 0.00%
2024-12-31 $-0.01B 0.00%
2024-09-30 $-0.01B 0.00%
2024-06-30 $-0.01B 0.00%
2024-03-31 $-0.01B 0.00%
2023-12-31 $-0.01B 0.00%
2023-09-30 $-0.01B 0.00%
2023-06-30 $-0.01B 0.00%
2023-03-31 $-0.01B 0.00%
2022-12-31 $-0.01B 0.00%
2022-09-30 $-0.01B 0.00%
2022-06-30 $-0.01B 0.00%
2022-03-31 $-0.01B 0.00%
2021-12-31 $-0.01B 0.00%
2021-09-30 $-0.01B 0.00%
2021-06-30 $-0.01B 0.00%
2021-03-31 $-0.01B 0.00%
2020-12-31 $-0.01B 0.00%
2020-09-30 $-0.01B 0.00%
2020-06-30 $-0.01B 0.00%
2020-03-31 $-0.01B 0.00%
2019-12-31 $-0.01B 0.00%
2019-09-30 $-0.01B 0.00%
2019-06-30 $-0.01B 0.00%
2019-03-31 $-0.01B -400.00%
2018-12-31 $-0.01B -153.85%
2018-09-30 $0.00B -88.89%
2018-06-30 $0.00B $0.01B -84.21%
2018-03-31 $0.00B $0.01B -123.08%
2017-12-31 $-0.01B $0.01B -285.71%
2017-09-30 $-0.01B $0.00B -1000.00%
2017-06-30 $-0.01B $0.00B -2400.00%
2017-03-31 $-0.01B $0.00B -1200.00%
2016-12-31 $-0.01B $0.00B -666.67%
2016-09-30 $-0.01B -666.67%
2016-06-30 $0.00B $0.00B -533.33%
2016-03-31 $0.00B $0.00B -800.00%
2015-12-31 $0.00B -1600.00%
2015-09-30 $0.00B -533.33%
2015-06-30 $0.00B -1600.00%
2015-03-31 $0.00B $0.00B 800.00%
2014-12-31 $0.00B $0.00B 94.12%
2014-09-30 $0.00B $0.00B 84.21%
2014-06-30 $0.00B $0.00B 70.59%
2014-03-31 $0.00B $-0.01B 85.71%
2013-12-31 $0.00B 0.00%
2013-09-30 $0.00B 0.00%
2013-06-30 $0.00B 0.00%
2013-03-31 $0.00B 0.00%
2012-12-31 $0.00B 0.00%
2012-09-30 $0.00B 0.00%
2012-06-30 $0.00B 0.00%
2012-03-31 $0.00B 0.00%
2011-12-31 $0.00B 0.00%
2011-09-30 $0.00B 0.00%
2011-06-30 $0.00B 0.00%
2011-03-31 $0.00B 0.00%
2010-12-31 $0.00B 0.00%
2010-09-30 $0.00B 0.00%
2010-06-30 $0.00B 0.00%
2010-03-31 $0.00B 0.00%
2009-12-31 $0.00B 0.00%
2009-09-30 $0.00B 0.00%
2009-06-30 $0.00B 0.00%
2009-03-31 $0.00B 0.00%
2008-12-31 $0.00B 0.00%
2008-09-30 $0.00B 0.00%
2008-06-30 $0.00B 0.00%
2008-03-31 $0.00B 0.00%
2007-12-31 $0.00B 0.00%
2007-09-30 $0.00B 0.00%
2007-06-30 $0.00B 0.00%
2007-03-31 $0.00B 0.00%
2006-12-31 $0.00B 0.00%
2006-09-30 $0.00B 0.00%
2006-06-30 $0.00B 0.00%
2006-03-31 $0.00B 0.00%
2005-12-31 $0.00B 0.00%
2005-09-30 $0.00B 0.00%
2005-06-30 $0.00B 0.00%
2005-03-31 $0.00B 0.00%
2004-12-31 $0.00B 0.00%
2004-09-30 $0.00B 0.00%
2004-06-30 $0.00B 0.00%
2004-03-31 $0.00B 0.00%
2003-12-31 $0.00B 0.00%
2003-09-30 $0.00B 0.00%
2003-06-30 $0.00B 0.00%
2003-03-31 $0.00B 0.00%
2002-12-31 $0.00B 0.00%
2002-09-30 $0.00B 133.33%
2002-06-30 $0.00B 80.00%
2002-03-31 $0.00B 114.29%
2001-12-31 $0.00B $0.00B 88.89%
2001-09-30 $0.00B $0.00B 114.29%
2001-06-30 $0.00B $0.00B 240.00%
2001-03-31 $0.00B $0.00B 400.00%
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.003B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $265.583B 17.98
Cigna Group (CI) United States $77.851B 9.76
Humana (HUM) United States $22.142B 10.75
Centene (CNC) United States $19.946B 19.80
Molina Healthcare (MOH) United States $6.971B 12.71
Select Medical Holdings (SEM) United States $2.028B 14.00
Joint (JYNT) United States $0.129B 0.00